Temple University Health System — Philadelphia, Pennsylvania

Temple University Health System is a clinical research site located in Philadelphia, Pennsylvania, United States 19140.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Temple University Health System has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Hypertension, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Gastrointestinal Stromal Tumor (GIST).

Sponsors: CVRx, Inc., Genfit, Kura Oncology, Inc..

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Temple University Health System?

Temple University Health System has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Temple University Health System conducted?

Temple University Health System has 6 clinical trials on record, with 1 currently active. Their work covers Hypertension, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Gastrointestinal Stromal Tumor (GIST).

Is Temple University Health System accredited by Crixeo Health?

Yes — Temple University Health System holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Temple University Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.